See more news releases in Health Care & Hospitals | Medical Pharmaceuticals | Pharmaceuticals

Cambrex to Announce Third Quarter 2012 Financial Results on October 31, 2012

EAST RUTHERFORD, N.J., Oct. 26, 2012 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM) announced that third quarter 2012 financial results will be released on Wednesday, October 31, 2012 after the market closes.

The Company will host a conference call to discuss the financial results.

Third Quarter 2012 Earnings Conference Call

When:	Thursday, November 1, 2012 at 8:30 a.m. Eastern Time

Dial-in:	1-888-430-8705 for U.S.
	1-719-325-2455 for International
	Passcode: 1704787

Dial-in Replay:	1-888-203-1112 for U.S.
	1-719-457-0820 for International
	Passcode: 1704787
	Available through Thursday, November 8, 2012

Webcast:	www.cambrex.com

About Cambrex

Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. We offer Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Our development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products. For more information, please visit www.cambrex.com.

SOURCE Cambrex Corporation